Onychomycosis: A significant medical disorder

Journal of the American Academy of Dermatology

Volumn 35, Issue 3 PART II, 1996, Pages

  Scher, Richard K ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ECONOMIC ASPECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; ONYCHOMYCOSIS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL ASPECT;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; HUMANS; ONYCHOMYCOSIS; QUALITY OF LIFE;

EID: 0029764340     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(96)90061-4     Document Type: Article

References (7)

1. Scher RK. Onychomycosis is more than a cosmetic problem. Br J Dermatol 1994;130(suppl 43):15.
2. Daniel CR. The diagnosis of nail fungal infection. Arch Dermatol 1991;127:1566-7.
3. Achten G, Wanet-Rouard J. Onychomycosis in the laboratory. Mykosen 1978;23:125-7.
4. André J, Achten G. Onychomycosis. Int J Dermatol 1987; 26:481-90.
5. Rippon JW. Dermatophytosis and dermatomycosis. In: Rippon JW, editor. Medical Mycology, 3rd ed. Philadelphia: WB Saunders Co, 1988:169-275.
6. Zaias N. Onychomycosis. In: Daniel CR III, editor. Dermatologic Clinics. Philadelphia: WB Saunders Co, 1985:445-60.
7. Rosenbach ML, Schneider JE. The burden of onychomycosis in the Medicare population. Health Economic Research Inc. Sandoz Pharmaceuticals Corporation (on file).